The Pathway of Part 2 Data in Research: Opioids, Covered Entities, and IRBs, Oh My!
-
Marti Arvin, Executive Advisor, CynergisTek, Inc..
June 1, 2020
-
Basic overview of Part 2 and the implications of recent proposed changes to the regulations
-
The complexity of protecting Part 2 data and ensuring appropriate availability and use in research
-
Educating the research team and the IRB on the requirements of Part 2
THIS DOCUMENT IS ONLY AVAILABLE TO MEMBERS OR ATTENDEES. PLEASE LOG IN OR PURCHASE ACCESS.
THIS RECORDING IS ONLY AVAILABLE TO ATTENDEES AND PURCHASERS. PLEASE LOG IN OR PURCHASE ACCESS.